Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omnisens is a Swiss-based technology company that specializes in high-performance fiber optic sensing and trace gas analysis solutions. While the company is widely recognized for its asset monitoring systems in the energy and infrastructure sectors, it maintains a significant presence in the life sciences through its advanced photoacoustic spectroscopy technology. This technology is utilized for non-invasive medical applications, including breath analysis for disease detection and plant physiology research. Following its acquisition by the Prysmian Group in 2021, Omnisens continues to provide precision instrumentation that bridges the gap between industrial sensing and biological monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Omnisens.